Arcadia Biosciences, Inc.

140 articles with Arcadia Biosciences, Inc.

• Arcadia Biosciences Granted U.S. Patent for Reduced Gluten GoodWheat

  9/23/2019

  Arcadia Biosciences, Inc. announced the U.S. Patent and Trademark Office has awarded the company a patent for reduced gluten grains.

• Arcadia Biosciences Announces $10 Million Registered Direct Offering Priced At-the-Market

  9/6/2019

  Arcadia Biosciences, Inc. (Nasdaq: RKDA), a food ingredient company and proven leader in agricultural innovation, improving the quality and nutritional content of crops, today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase of 1,318,828 shares of its common stock, at a purchase price per share of $7.5825,

• Arcadia Biosciences to Present at 21st Annual Global Investment Conference September 8-10, 2019

  9/4/2019

  Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, announced today that it will be presenting at the 21st Annual Global Investment Conference, sponsored by H.C. Wainwright & Co. LLC.

• Arcadia Biosciences Announces Management Succession; Provides Financial Guidance

  8/26/2019

  Arcadia Biosciences, Inc. announced that Raj Ketkar, president and CEO, will retire effective September 1, 2019.

• Arcadia Biosciences Enters Global Collaboration with Arista Cereal Technologies and Bay State Milling Company for Commercialization of High Fiber Wheat

  8/26/2019

  Arcadia Biosciences, Inc. announced a binding term sheet agreement with Arista Cereal Technologies and Bay State Milling Company for commercialization of its high fiber resistant starch wheat in key wheat markets, including North America, Europe and parts of Asia.

• /C O R R E C T I O N -- Arcadia Biosciences, Inc./

  8/5/2019

  Arcadia Biosciences, Inc. announced its plan to release its second-quarter 2019 financial and business results after market close on August 14, 2019.

• Arcadia Biosciences Announces Date of Second-Quarter 2019 Financial Results and Business Highlights Conference Call

  8/5/2019

  Arcadia Biosciences, Inc. announced its plan to release its second-quarter 2019 financial and business results after market close on August 7, 2019.

• Arcadia Biosciences Announces Closing of $7.5 Million Registered Direct Offering Priced At-the-Market

  6/18/2019

  Net Proceeds to Fuel Hemp Research, Innovation and Scale-Up of GoodWheat™

• Arcadia Biosciences Announces First-Quarter 2019 Financial Results and Business Highlights

  5/8/2019

  Company launches new business unit, Arcadia Specialty Genomics™, to apply its advanced plant breeding and gene editing expertise to cannabis

• Arcadia Biosciences Announces Date of First-Quarter 2019 Financial Results and Business Highlights Conference Call

  5/1/2019

  Plans to release its first-quarter 2019 financial and business results after market close on May 8, 2019.

• 

  BioSpace Movers and Shakers: April 12

  4/12/2019

  Biopharma companies tap new hires to assume roles in leadership positions, with additions at Metrion, JDRF, Ribometrix, and more.

• Arcadia Biosciences Welcomes Dr. Randy Shultz as Head of Research and Development

  4/9/2019

  Experienced R&D strategist brings deep expertise in advanced breeding and gene editing technologies

• Arcadia Biosciences Announces Fourth-Quarter and Full-Year 2018 Financial Results and Business Highlights

  3/27/2019

  Arcadia Biosciences, Inc. (Nasdaq: RKDA), a food ingredient company and proven leader in agricultural innovation, improving the quality and nutritional content of crops, today released its financial and business results for the fourth quarter and full year of 2018.

• Verdeca Introduces HB4® Drought Tolerant Soybeans to Growers at Argentina’s Expoagro

  3/26/2019

  Highly favorable response to pre-commercial introduction of HB4 technology

• Arcadia Biosciences to Present at The Spring Investor Summit April 1-2, 2019

  3/26/2019

  Arcadia Biosciences, Inc. announced that it will be featured as a presenting company at The Spring Investor Summit.

• Arcadia Biosciences Receives FDA Approval for SONOVA® GLA Safflower Oil in Cat Food

  3/15/2019

  SONOVA GLA offers cat food manufacturers a sustainable, plant-based source of essential omega-6 fatty acid

• Arcadia Biosciences Receives Its First Industrial Hemp Program License in Hawaii

  3/4/2019

  The company’s new cannabis-dedicated operating unit, Arcadia Specialty Genomics, will commence research this April with a new 10-acre hemp cultivation facility.

• Arcadia Biosciences, a Leader in Advanced Agricultural Breeding and Gene Optimization, Announces New Business Unit Dedicated to Cannabis

  2/28/2019

  Arcadia Specialty Genomics to bring standardization and optimization to America’s cannabis crop with a focus on improved plant quality, resiliency and yield.

• Arcadia Biosciences’ GoodWheat™ Supply Chain Is Progressing in Two Hemispheres

  2/7/2019

  Winter planting expands acres and builds supply for commercial launch

• Arista Cereal Technologies Announces Dismissal of Patent Dispute With Arcadia Biosciences Over High Fiber Wheat

  1/24/2019

  Arista Cereal Technologies Pty Ltd (ARISTA) announces that the lawsuit initiated by Arcadia Biosciences Inc. against ARISTA in the District Court for the Southern District of New York (SDNY) has been dismissed.